Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Gastroenterology and Hepathology

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00042737-200312000-00010PMID 14624155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-alcoholic steatohepatitis.

  2005cited by this paper
• Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines.

  2002cited by this paper
• Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14

  2002cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper
• Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

  2001cited by this paper
• Nonalcoholic steatohepatitis.

  2001cited by this paper
• Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease

  2001cited by this paper
• A Common Single Nucleotide Polymorphism in the CD14 Promoter Decreases the Affinity of Sp Protein Binding and Enhances Transcriptional Activity1

  2001cited by this paper
• Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.

  2001cited by this paper
• Release of Endotoxin-binding Proteins during Major Elective Surgery: Role of Soluble CD14 in Phagocytic Activation

  2000cited by this paper
• Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

  2000cited by this paper
• Soluble CD14 acts as a negative regulator of human T cell activation and function

  1999cited by this paper
• A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.

  1999cited by this paper
• C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction.

  1999cited by this paper
• Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.

  1998cited by this paper
• Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis

  1997cited by this paper
• C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

  1996cited by this paper
• Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide

  1994cited by this paper
• Sp1 is a critical factor for the monocytic specific expression of human CD14.

  1994cited by this paper
• CD14: cell surface receptor and differentiation marker.

  1993cited by this paper
• Immunophenotyping of lymphocytes in liver tissue of patients with chronic liver diseases by flow cytometry

  1991cited by this paper
• CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

  1990cited by this paper
• Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells.

  1989cited by this paper
• Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity.

  1989cited by this paper
• The liver in Crohn's disease.

  1971cited by this paper

• CD14/-159 and TNFα/-308 Promoter Polymorphisms are not associated with Development of Idiopathic Neonatal Hepatitis among Filipinos

  2017cites this paper
• Liver enzyme levels in relation to a common polymorphism in the CD14 promoter gene.

  2007cites this paper
• Reports of HHV-6-induced complications occurring in patients on immunosuppressive therapy after solid-organ transplantation [6] may justify future screening of patients with DHS (or DRESS) for HHV-6 infection

  2007cites this paper
• Family history of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease: Central obesity the likely link.

  2007cites this paper
• Common promoter polymorphism in monocyte differentiation antigen CD14 is associated with serum triglyceride levels and body mass index in non‐diabetic individuals

  2006cites this paper
• Review article: alcoholic liver disease – pathophysiological aspects and risk factors

  2006cites this paper
• The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers.

  2005cites this paper
• Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection.

  2005influential citation
• Nutrition and physiological function

  2003cites this paper